0001209191-23-018013.txt : 20230310
0001209191-23-018013.hdr.sgml : 20230310
20230310195136
ACCESSION NUMBER: 0001209191-23-018013
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230309
FILED AS OF DATE: 20230310
DATE AS OF CHANGE: 20230310
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Detheux Michel
CENTRAL INDEX KEY: 0001816196
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39401
FILM NUMBER: 23725339
MAIL ADDRESS:
STREET 1: C/O ITEOS THERAPEUTICS, INC.
STREET 2: 139 MAIN STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: iTeos Therapeutics, Inc.
CENTRAL INDEX KEY: 0001808865
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 321 ARSENAL STREET
STREET 2: BLDG 312, FLOOR 3, SUITE 301
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: 857-204-4583
MAIL ADDRESS:
STREET 1: 321 ARSENAL STREET
STREET 2: BLDG 312, FLOOR 3, SUITE 301
CITY: WATERTOWN
STATE: MA
ZIP: 02472
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-03-09
0
0001808865
iTeos Therapeutics, Inc.
ITOS
0001816196
Detheux Michel
321 ARSENAL STREET
WATERTOWN
MA
02472
0
1
0
0
Chief Executive Officer
Stock Option (Right to Buy)
16.66
2023-03-09
4
A
0
346000
0.00
A
2033-03-09
Common Stock
346000
346000
D
Stock Option (Right to Buy)
16.66
2023-03-09
4
G
0
254997
0.00
D
2033-03-09
Common Stock
254997
91003
D
Stock Option (Right to Buy)
16.66
2023-03-09
4
G
0
254997
0.00
A
2033-03-09
Common Stock
254997
254997
I
By MG3A
This stock option shall vest over four years, with 25% vesting on March 9, 2024 and thereafter in equal monthly installments over the next 36 months, subject to the reporting person's continued service to the Issuer.
The reporting person transferred these stock options to MG3A, a Belgian partnership of which the reporting person is the manager and the reporting person's spouse is the successor manager.
/s/ Adi Osovsky, as Attorney-in-Fact
2023-03-10